"Homate Street Goroka Eastern Highlands Province"

During the past decade, Papua New Guinea Institute of Medical Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Papua New Guinea Institute of Medical Research" #1 sponsor was "Papua New Guinea Institute of Medical Research" with 2 trials, followed by "Washington University School of Medicine" with 2 trials sponsored, "Menzies School of Health Research" with 1 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored and "University of Melbourne" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Papua New Guinea Institute of Medical Research" #1 collaborator was "Case Western Reserve University" with 3 trials as a collaborator, "University of Melbourne" with 3 trials as a collaborator, "Papua New Guinea Institute of Medical Research" with 2 trials as a collaborator, "The University of Western Australia" with 2 trials as a collaborator and "Curtin University" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Papua New Guinea Institute of Medical Research" are "Malaria" (2 trials), "Malaria in Pregnancy" (2 trials), "Anaemia" (1 trials), "Anemia" (1 trials) and "Clinical Efficacy" (1 trials). Many other conditions were trialed in "Papua New Guinea Institute of Medical Research" in a lesser frequency.

Most popular intervention types in "Papua New Guinea Institute of Medical Research" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "2 drug dose - DA" (2 trials), "3 drug dose - IDA" (2 trials), "Amodiaquine/sulphadoxine-pyrimethamine, Artesunate/sulphadoxine-pyrimethamine or placebo" (1 trials), "Azithromycin plus piperaquine phosphate" (1 trials) and "Dihydroartemisinin-Piperaquine (DP)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Papua New Guinea Institute of Medical Research" are 4 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Papua New Guinea Institute of Medical Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Papua New Guinea Institute of Medical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Papua New Guinea Institute of Medical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".